Trial: 202103204

A Phase 1, Open-Label, Dose-Finding Study of CC-91633 (BMS-986397) in Subjects with Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes



Principal Investigator

Uy, Geoffrey

Disease Site

Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Myeloid and Monocytic Leukemia; Other Hematopoietic

Learn more about this study at: